En Es

Industry News

Health Summit to Play Greater Role in Chinese Health Industry

By HospiMedica International staff writers
09 May 2018

Image: The Health Industry Summit 2018 covered the entire industry value chain, including key segments such as medical devices, pharmaceutical production, drug distribution and natural health and nutrition (Photo courtesy of tHIS).The Health Industry Summit (tHIS) 2018 held at the National Exhibition and Convention Center in Shanghai on April 11, 2018, was the largest gathering of healthcare industry professionals in the world with well over 200,000 attendees from more than 150 countries and regions and over 7,000 exhibitors. The fourth edition of tHIS covered an exhibition space of over 350,000 square meters with 160 individual events and conferences being held alongside the main expo.

tHIS 2018 is fast becoming China's solution for promoting technology innovations and academic exchange in the medical healthcare arena. China is the second-largest healthcare market in the world and is one of the most attractive in the world for foreign investors. A recent report from McKinsey & Co. estimates China's healthcare market to grow at an unprecedented CAGR of about 12% from USD 357 billion in 2011 to reach USD 1 trillion by 2020. The growth of the Chinese healthcare market is expected to be driven mainly by the country’s ageing population, rise in incidences of lifestyle related diseases such as diabetes and cancer, and major steps taken by the government to improve the local healthcare infrastructure. Recent regulatory changes by the Chinese government are expected to speed up the approvals of medicines and medical devices, thus easing the process of introducing new treatments to the market.

Additionally, under its “Made in China 2025” plan, the Chinese government is focusing on the development of high-performance devices such as diagnostic imaging equipment, robotic surgery devices, high-end medical consumables, including fully degradable cardiovascular stents, wearable devices, and telemedicine. With local companies increasing their technological capabilities and producing high-end medical devices, China’s medical device market will continue to strengthen even as the competition between the players intensifies.

In line with the call by Chinese President Xi for greater promotion of the country’s health industry at the Boao Forum for Asia, tHIS 2018 covered the entire industry value chain, including key segments such as medical devices, pharmaceutical production, drug distribution and natural health and nutrition. The key events at the four-day summit included China's top medical equipment and pharmaceutical exhibitions CMEF, PHARMCHINA and API China, which showcased cutting-edge technologies such as virtual reality, augmented reality, wearables and artificial intelligence as part of the new Intelligent Health exhibition. The show also highlighted traditional medicine as China's own solutions for treatment and prevention, which runs parallel to modern medicine and drug development.

Various medical device giants such as GE, United Imaging, Siemens, Philips and Mindray as well as major pharmaceutical groups in China including Sinopharm, Shanghai Pharma and CR Pharmaceuticals used the show as a platform to launch more than 600 new products for the global or Asia Pacific markets.

tHIS 218 was hosted by Reed Sinopharm, a joint venture between the world's leading event organizer Reed Exhibitions and China's state-owned medical & pharmaceutical giant Sinopharm. The next edition of the event is scheduled to be held in May 2019 in Shanghai.

Related Links:
Reed Sinopharm

E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

21 Mar 2019
Baxter and bioMérieux in Alliance to Develop Acute Kidney Injury Diagnostics
Baxter International Inc. and bioMérieux announced an agreement to develop future biomarkers with the goal to rapidly identify and inform treatment of acute kidney injury (AKI).
Read More
19 Mar 2019
Advantech Launches All-in-One Computer for Healthcare Applications
Advantech, a provider of medical computing systems, has launched its POC-L series of non-medical-grade point-of-care touch computers comprising two models differentiated according to their display size – POC-W213L (21.5 inches) and POC-W243L (23.8 inches).
Read More
19 Mar 2019
AI Algorithm Identifies Lung Tumors Faster Than Other Methods
Computing scientists at the University of Alberta have developed a neural network that outperforms other state-of-the-art methods of identifying lung tumors from MRI scans—creating the potential to help reduce damage to healthy tissue during radiation treatment.
Read More
19 Mar 2019
Machine Learning Method Can Help Women Avoid Unnecessary Breast Surgery
A team of researchers from the Geisel School of Medicine at Dartmouth has developed a machine learning method to predict atypical ductal hyperplasia (ADH) upgrade to cancer.
Read More
19 Mar 2019
First AI-Based Tool for Pulmonary Embolism Receives CE Certification
Aidoc, a provider of artificial intelligence (AI) solutions for radiologists, has announced the commercial release of its CE-marked product for the identification and triage of pulmonary embolism (PE) in CT pulmonary angiograms.
Read More
19 Mar 2019
World’s First AI-Based Algorithms for ED Receive CE Certification
Zebra Medical Vision has received two new CE marked registrations for its deep learning algorithms that help radiologists and Emergency Room (ER) staff to prioritize acute conditions for the first time in both CT scans and X-rays and reduce reports turnaround time (RTAT).
Read More
19 Mar 2019
Global Neonatal Ventilator Market to Surpass USD 466 Million by 2025
The global neonatal ventilator market is expected to surpass USD 466.1 million by 2025 as rising incidences of preterm births with respiratory disorders and mortality rates will drive the demand for various neonatal ventilators worldwide.
Read More
11 Mar 2019
Carestream Health to Sell Healthcare IT Business to Philips
Carestream Health has entered into an agreement with Royal Philips to sell its healthcare information systems (HCIS) business to Philips.
Read More
07 Mar 2019
Investments in AI Imaging Start-ups Increased to USD 580 Million in 2018
Capital investments in start-up companies developing medical imaging artificial intelligence (AI) solutions more than doubled to USD 580 million in 2018 from USD 270 million in 2017.
Read More
Copyright © 2000-2019 TradeMed.com. All rights reserved. | Terms And Conditions